Cargando…
An analysis of common ethical justifications for compassionate use programs for experimental drugs
BACKGROUND: When a new intervention or drug is developed, this has to pass through various phases of clinical testing before it achieves market approval, which can take many years. This raises an issue for drugs which could benefit terminally ill patients. These patients might set their hopes on the...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5069844/ https://www.ncbi.nlm.nih.gov/pubmed/27756370 http://dx.doi.org/10.1186/s12910-016-0145-x |